The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pneumococcal Vaccination Market Research Report 2025
Synopsis
Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.
The global Pneumococcal Vaccination market was valued at US$ 7841.5 million in 2023 and is anticipated to reach US$ 16100 million by 2030, witnessing a CAGR of 10.6% during the forecast period 2024-2030.
The pneumococcal vaccination market is driven by the increasing awareness of the importance of vaccination and the rising incidence of pneumococcal infections. Pneumococcal vaccines are crucial in preventing diseases caused by Streptococcus pneumoniae bacteria, such as pneumonia, meningitis, and bacteremia. The rise in the geriatric population and the need for immunization against respiratory infections contribute to market growth as pneumococcal vaccines offer significant benefits in reducing morbidity and mortality. Moreover, advancements in vaccine technology, such as the introduction of conjugate vaccines for broader protection, have improved vaccine efficacy. However, the market also faces challenges, including vaccine supply constraints and the need for continuous research to address emerging pneumococcal serotypes and strains. Additionally, addressing vaccine hesitancy and increasing vaccination coverage in underserved populations can pose obstacles for comprehensive disease prevention. To succeed, companies must focus on research and development to offer innovative and affordable pneumococcal vaccines, collaborate with healthcare providers to promote vaccination recommendations, and address the challenges to meet the increasing demand for effective and accessible protection against pneumococcal infections.
This report aims to provide a comprehensive presentation of the global market for Pneumococcal Vaccination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pneumococcal Vaccination.
Report Scope
The Pneumococcal Vaccination market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pneumococcal Vaccination market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pneumococcal Vaccination manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
GSK
MSD
CDIBP
WALVAX
Sinovac
Bio Kangtai
Segment by Type
PPSV 23
PCV 13
PCV 10
Segment by Application
Child
Adult
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pneumococcal Vaccination manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pneumococcal Vaccination in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.
The global Pneumococcal Vaccination market was valued at US$ 7841.5 million in 2023 and is anticipated to reach US$ 16100 million by 2030, witnessing a CAGR of 10.6% during the forecast period 2024-2030.
The pneumococcal vaccination market is driven by the increasing awareness of the importance of vaccination and the rising incidence of pneumococcal infections. Pneumococcal vaccines are crucial in preventing diseases caused by Streptococcus pneumoniae bacteria, such as pneumonia, meningitis, and bacteremia. The rise in the geriatric population and the need for immunization against respiratory infections contribute to market growth as pneumococcal vaccines offer significant benefits in reducing morbidity and mortality. Moreover, advancements in vaccine technology, such as the introduction of conjugate vaccines for broader protection, have improved vaccine efficacy. However, the market also faces challenges, including vaccine supply constraints and the need for continuous research to address emerging pneumococcal serotypes and strains. Additionally, addressing vaccine hesitancy and increasing vaccination coverage in underserved populations can pose obstacles for comprehensive disease prevention. To succeed, companies must focus on research and development to offer innovative and affordable pneumococcal vaccines, collaborate with healthcare providers to promote vaccination recommendations, and address the challenges to meet the increasing demand for effective and accessible protection against pneumococcal infections.
This report aims to provide a comprehensive presentation of the global market for Pneumococcal Vaccination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pneumococcal Vaccination.
Report Scope
The Pneumococcal Vaccination market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pneumococcal Vaccination market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pneumococcal Vaccination manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
GSK
MSD
CDIBP
WALVAX
Sinovac
Bio Kangtai
Segment by Type
PPSV 23
PCV 13
PCV 10
Segment by Application
Child
Adult
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pneumococcal Vaccination manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pneumococcal Vaccination in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Pneumococcal Vaccination Market Overview
1.1 Product Overview and Scope of Pneumococcal Vaccination
1.2 Pneumococcal Vaccination Segment by Type
1.2.1 Global Pneumococcal Vaccination Market Value Comparison by Type (2024-2030)
1.2.2 PPSV 23
1.2.3 PCV 13
1.2.4 PCV 10
1.3 Pneumococcal Vaccination Segment by Application
1.3.1 Global Pneumococcal Vaccination Market Value by Application: (2024-2030)
1.3.2 Child
1.3.3 Adult
1.4 Global Pneumococcal Vaccination Market Size Estimates and Forecasts
1.4.1 Global Pneumococcal Vaccination Revenue 2019-2030
1.4.2 Global Pneumococcal Vaccination Sales 2019-2030
1.4.3 Global Pneumococcal Vaccination Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pneumococcal Vaccination Market Competition by Manufacturers
2.1 Global Pneumococcal Vaccination Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pneumococcal Vaccination Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pneumococcal Vaccination Average Price by Manufacturers (2019-2024)
2.4 Global Pneumococcal Vaccination Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pneumococcal Vaccination, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pneumococcal Vaccination, Product Type & Application
2.7 Pneumococcal Vaccination Market Competitive Situation and Trends
2.7.1 Pneumococcal Vaccination Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pneumococcal Vaccination Players Market Share by Revenue
2.7.3 Global Pneumococcal Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pneumococcal Vaccination Retrospective Market Scenario by Region
3.1 Global Pneumococcal Vaccination Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pneumococcal Vaccination Global Pneumococcal Vaccination Sales by Region: 2019-2030
3.2.1 Global Pneumococcal Vaccination Sales by Region: 2019-2024
3.2.2 Global Pneumococcal Vaccination Sales by Region: 2025-2030
3.3 Global Pneumococcal Vaccination Global Pneumococcal Vaccination Revenue by Region: 2019-2030
3.3.1 Global Pneumococcal Vaccination Revenue by Region: 2019-2024
3.3.2 Global Pneumococcal Vaccination Revenue by Region: 2025-2030
3.4 North America Pneumococcal Vaccination Market Facts & Figures by Country
3.4.1 North America Pneumococcal Vaccination Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pneumococcal Vaccination Sales by Country (2019-2030)
3.4.3 North America Pneumococcal Vaccination Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pneumococcal Vaccination Market Facts & Figures by Country
3.5.1 Europe Pneumococcal Vaccination Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pneumococcal Vaccination Sales by Country (2019-2030)
3.5.3 Europe Pneumococcal Vaccination Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pneumococcal Vaccination Market Facts & Figures by Country
3.6.1 Asia Pacific Pneumococcal Vaccination Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pneumococcal Vaccination Sales by Country (2019-2030)
3.6.3 Asia Pacific Pneumococcal Vaccination Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Pneumococcal Vaccination Market Facts & Figures by Country
3.7.1 Latin America Pneumococcal Vaccination Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pneumococcal Vaccination Sales by Country (2019-2030)
3.7.3 Latin America Pneumococcal Vaccination Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pneumococcal Vaccination Market Facts & Figures by Country
3.8.1 Middle East and Africa Pneumococcal Vaccination Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pneumococcal Vaccination Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pneumococcal Vaccination Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pneumococcal Vaccination Sales by Type (2019-2030)
4.1.1 Global Pneumococcal Vaccination Sales by Type (2019-2024)
4.1.2 Global Pneumococcal Vaccination Sales by Type (2025-2030)
4.1.3 Global Pneumococcal Vaccination Sales Market Share by Type (2019-2030)
4.2 Global Pneumococcal Vaccination Revenue by Type (2019-2030)
4.2.1 Global Pneumococcal Vaccination Revenue by Type (2019-2024)
4.2.2 Global Pneumococcal Vaccination Revenue by Type (2025-2030)
4.2.3 Global Pneumococcal Vaccination Revenue Market Share by Type (2019-2030)
4.3 Global Pneumococcal Vaccination Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pneumococcal Vaccination Sales by Application (2019-2030)
5.1.1 Global Pneumococcal Vaccination Sales by Application (2019-2024)
5.1.2 Global Pneumococcal Vaccination Sales by Application (2025-2030)
5.1.3 Global Pneumococcal Vaccination Sales Market Share by Application (2019-2030)
5.2 Global Pneumococcal Vaccination Revenue by Application (2019-2030)
5.2.1 Global Pneumococcal Vaccination Revenue by Application (2019-2024)
5.2.2 Global Pneumococcal Vaccination Revenue by Application (2025-2030)
5.2.3 Global Pneumococcal Vaccination Revenue Market Share by Application (2019-2030)
5.3 Global Pneumococcal Vaccination Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Pneumococcal Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Pneumococcal Vaccination Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Pneumococcal Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Pneumococcal Vaccination Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 MSD
6.3.1 MSD Corporation Information
6.3.2 MSD Description and Business Overview
6.3.3 MSD Pneumococcal Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.3.4 MSD Pneumococcal Vaccination Product Portfolio
6.3.5 MSD Recent Developments/Updates
6.4 CDIBP
6.4.1 CDIBP Corporation Information
6.4.2 CDIBP Description and Business Overview
6.4.3 CDIBP Pneumococcal Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CDIBP Pneumococcal Vaccination Product Portfolio
6.4.5 CDIBP Recent Developments/Updates
6.5 WALVAX
6.5.1 WALVAX Corporation Information
6.5.2 WALVAX Description and Business Overview
6.5.3 WALVAX Pneumococcal Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.5.4 WALVAX Pneumococcal Vaccination Product Portfolio
6.5.5 WALVAX Recent Developments/Updates
6.6 Sinovac
6.6.1 Sinovac Corporation Information
6.6.2 Sinovac Description and Business Overview
6.6.3 Sinovac Pneumococcal Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sinovac Pneumococcal Vaccination Product Portfolio
6.6.5 Sinovac Recent Developments/Updates
6.7 Bio Kangtai
6.6.1 Bio Kangtai Corporation Information
6.6.2 Bio Kangtai Description and Business Overview
6.6.3 Bio Kangtai Pneumococcal Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bio Kangtai Pneumococcal Vaccination Product Portfolio
6.7.5 Bio Kangtai Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pneumococcal Vaccination Industry Chain Analysis
7.2 Pneumococcal Vaccination Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pneumococcal Vaccination Production Mode & Process
7.4 Pneumococcal Vaccination Sales and Marketing
7.4.1 Pneumococcal Vaccination Sales Channels
7.4.2 Pneumococcal Vaccination Distributors
7.5 Pneumococcal Vaccination Customers
8 Pneumococcal Vaccination Market Dynamics
8.1 Pneumococcal Vaccination Industry Trends
8.2 Pneumococcal Vaccination Market Drivers
8.3 Pneumococcal Vaccination Market Challenges
8.4 Pneumococcal Vaccination Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Pneumococcal Vaccination Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Pneumococcal Vaccination Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Pneumococcal Vaccination Market Competitive Situation by Manufacturers in 2023
Table 4. Global Pneumococcal Vaccination Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Pneumococcal Vaccination Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Pneumococcal Vaccination Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Pneumococcal Vaccination Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Pneumococcal Vaccination Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Pneumococcal Vaccination, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Pneumococcal Vaccination, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pneumococcal Vaccination, Product Type & Application
Table 12. Global Key Manufacturers of Pneumococcal Vaccination, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pneumococcal Vaccination by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumococcal Vaccination as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pneumococcal Vaccination Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Pneumococcal Vaccination Sales by Region (2019-2024) & (K Units)
Table 18. Global Pneumococcal Vaccination Sales Market Share by Region (2019-2024)
Table 19. Global Pneumococcal Vaccination Sales by Region (2025-2030) & (K Units)
Table 20. Global Pneumococcal Vaccination Sales Market Share by Region (2025-2030)
Table 21. Global Pneumococcal Vaccination Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Pneumococcal Vaccination Revenue Market Share by Region (2019-2024)
Table 23. Global Pneumococcal Vaccination Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Pneumococcal Vaccination Revenue Market Share by Region (2025-2030)
Table 25. North America Pneumococcal Vaccination Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Pneumococcal Vaccination Sales by Country (2019-2024) & (K Units)
Table 27. North America Pneumococcal Vaccination Sales by Country (2025-2030) & (K Units)
Table 28. North America Pneumococcal Vaccination Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Pneumococcal Vaccination Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Pneumococcal Vaccination Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Pneumococcal Vaccination Sales by Country (2019-2024) & (K Units)
Table 32. Europe Pneumococcal Vaccination Sales by Country (2025-2030) & (K Units)
Table 33. Europe Pneumococcal Vaccination Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Pneumococcal Vaccination Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Pneumococcal Vaccination Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Pneumococcal Vaccination Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Pneumococcal Vaccination Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Pneumococcal Vaccination Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Pneumococcal Vaccination Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Pneumococcal Vaccination Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Pneumococcal Vaccination Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Pneumococcal Vaccination Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Pneumococcal Vaccination Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Pneumococcal Vaccination Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Pneumococcal Vaccination Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Pneumococcal Vaccination Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Pneumococcal Vaccination Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Pneumococcal Vaccination Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Pneumococcal Vaccination Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Pneumococcal Vaccination Sales (K Units) by Type (2019-2024)
Table 51. Global Pneumococcal Vaccination Sales (K Units) by Type (2025-2030)
Table 52. Global Pneumococcal Vaccination Sales Market Share by Type (2019-2024)
Table 53. Global Pneumococcal Vaccination Sales Market Share by Type (2025-2030)
Table 54. Global Pneumococcal Vaccination Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Pneumococcal Vaccination Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Pneumococcal Vaccination Revenue Market Share by Type (2019-2024)
Table 57. Global Pneumococcal Vaccination Revenue Market Share by Type (2025-2030)
Table 58. Global Pneumococcal Vaccination Price (US$/Unit) by Type (2019-2024)
Table 59. Global Pneumococcal Vaccination Price (US$/Unit) by Type (2025-2030)
Table 60. Global Pneumococcal Vaccination Sales (K Units) by Application (2019-2024)
Table 61. Global Pneumococcal Vaccination Sales (K Units) by Application (2025-2030)
Table 62. Global Pneumococcal Vaccination Sales Market Share by Application (2019-2024)
Table 63. Global Pneumococcal Vaccination Sales Market Share by Application (2025-2030)
Table 64. Global Pneumococcal Vaccination Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Pneumococcal Vaccination Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Pneumococcal Vaccination Revenue Market Share by Application (2019-2024)
Table 67. Global Pneumococcal Vaccination Revenue Market Share by Application (2025-2030)
Table 68. Global Pneumococcal Vaccination Price (US$/Unit) by Application (2019-2024)
Table 69. Global Pneumococcal Vaccination Price (US$/Unit) by Application (2025-2030)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Pneumococcal Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Pfizer Pneumococcal Vaccination Product
Table 74. Pfizer Recent Developments/Updates
Table 75. GSK Corporation Information
Table 76. GSK Description and Business Overview
Table 77. GSK Pneumococcal Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. GSK Pneumococcal Vaccination Product
Table 79. GSK Recent Developments/Updates
Table 80. MSD Corporation Information
Table 81. MSD Description and Business Overview
Table 82. MSD Pneumococcal Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. MSD Pneumococcal Vaccination Product
Table 84. MSD Recent Developments/Updates
Table 85. CDIBP Corporation Information
Table 86. CDIBP Description and Business Overview
Table 87. CDIBP Pneumococcal Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. CDIBP Pneumococcal Vaccination Product
Table 89. CDIBP Recent Developments/Updates
Table 90. WALVAX Corporation Information
Table 91. WALVAX Description and Business Overview
Table 92. WALVAX Pneumococcal Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. WALVAX Pneumococcal Vaccination Product
Table 94. WALVAX Recent Developments/Updates
Table 95. Sinovac Corporation Information
Table 96. Sinovac Description and Business Overview
Table 97. Sinovac Pneumococcal Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Sinovac Pneumococcal Vaccination Product
Table 99. Sinovac Recent Developments/Updates
Table 100. Bio Kangtai Corporation Information
Table 101. Bio Kangtai Description and Business Overview
Table 102. Bio Kangtai Pneumococcal Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Bio Kangtai Pneumococcal Vaccination Product
Table 104. Bio Kangtai Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Pneumococcal Vaccination Distributors List
Table 108. Pneumococcal Vaccination Customers List
Table 109. Pneumococcal Vaccination Market Trends
Table 110. Pneumococcal Vaccination Market Drivers
Table 111. Pneumococcal Vaccination Market Challenges
Table 112. Pneumococcal Vaccination Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pneumococcal Vaccination
Figure 2. Global Pneumococcal Vaccination Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Pneumococcal Vaccination Market Share by Type in 2023 & 2030
Figure 4. PPSV 23 Product Picture
Figure 5. PCV 13 Product Picture
Figure 6. PCV 10 Product Picture
Figure 7. Global Pneumococcal Vaccination Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Pneumococcal Vaccination Market Share by Application in 2023 & 2030
Figure 9. Child
Figure 10. Adult
Figure 11. Global Pneumococcal Vaccination Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Pneumococcal Vaccination Market Size (2019-2030) & (US$ Million)
Figure 13. Global Pneumococcal Vaccination Sales (2019-2030) & (K Units)
Figure 14. Global Pneumococcal Vaccination Average Price (US$/Unit) & (2019-2030)
Figure 15. Pneumococcal Vaccination Report Years Considered
Figure 16. Pneumococcal Vaccination Sales Share by Manufacturers in 2023
Figure 17. Global Pneumococcal Vaccination Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Pneumococcal Vaccination Players: Market Share by Revenue in 2023
Figure 19. Pneumococcal Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Pneumococcal Vaccination Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Pneumococcal Vaccination Sales Market Share by Country (2019-2030)
Figure 22. North America Pneumococcal Vaccination Revenue Market Share by Country (2019-2030)
Figure 23. United States Pneumococcal Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Pneumococcal Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Pneumococcal Vaccination Sales Market Share by Country (2019-2030)
Figure 26. Europe Pneumococcal Vaccination Revenue Market Share by Country (2019-2030)
Figure 27. Germany Pneumococcal Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Pneumococcal Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Pneumococcal Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Pneumococcal Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Pneumococcal Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Pneumococcal Vaccination Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Pneumococcal Vaccination Revenue Market Share by Region (2019-2030)
Figure 34. China Pneumococcal Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Pneumococcal Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Pneumococcal Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Pneumococcal Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Pneumococcal Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Pneumococcal Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Pneumococcal Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Pneumococcal Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Pneumococcal Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Pneumococcal Vaccination Sales Market Share by Country (2019-2030)
Figure 44. Latin America Pneumococcal Vaccination Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Pneumococcal Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Pneumococcal Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Pneumococcal Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Pneumococcal Vaccination Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Pneumococcal Vaccination Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Pneumococcal Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Pneumococcal Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Pneumococcal Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Pneumococcal Vaccination by Type (2019-2030)
Figure 54. Global Revenue Market Share of Pneumococcal Vaccination by Type (2019-2030)
Figure 55. Global Pneumococcal Vaccination Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Pneumococcal Vaccination by Application (2019-2030)
Figure 57. Global Revenue Market Share of Pneumococcal Vaccination by Application (2019-2030)
Figure 58. Global Pneumococcal Vaccination Price (US$/Unit) by Application (2019-2030)
Figure 59. Pneumococcal Vaccination Value Chain
Figure 60. Pneumococcal Vaccination Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
